Tata Chemicals Ltd
Tata Chemicals Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
India is showing robust demand growth with higher capacity utilization across all sectors. Tata Chemicals is focused on disciplined execution, supply chain strengthening, and cost and cash flow discipline to improve margins and profitability over the next few quarters (Page 16).
From Tata Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- India is showing robust demand growth with higher capacity utilization across all sectors.
- Solar glass sector expected to drive incremental demand, with initial demand of 7,500-10,000 tons per month as new solar glass capacities commercialize.
- The company is repurposing a cement plant to dense ash production to meet growing solar glass demand, anticipating at least 50% utilization initially.
- Focus on increasing non-soda ash revenue, which grew 14% from INR 6,118 crores in FY25 to INR 6,946 crores in FY26.
- Reduced imports due to geopolitical tensions are boosting domestic volumes and demand.
- Capacity expansions and debottlenecking projects underway with capex expected to yield 15-20% IRR, supporting volume growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Tata Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR 1,300 crores Capex for FY27 primarily on:
- Maintenance capex at Mithapur and US plants
- Growth capex in South India (notably Silica plant at Cuddalore)
- Capex for the recently acquired Singapore company
- Silica Plant at Cuddalore: INR 775 crores investment for 50,000 tons capacity; detailed revenue/EBITDA guidance to be provided in Q1 FY27 call.
- Dense Ash Plant: Repurposing existing cement plant to dense ash production to meet solar glass demand with expected 50% utilization initially.
- Other Projects:
- INR 100 crores immediate debottlenecking capex with expected IRR >20%.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Tata Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Tata Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.4K Cr, net loss ₹2.1K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tata Chemicals's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
- Chemfab Alkalis Ltd (Q4 FY26)
Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…
- Sudarshan Pharma Industries Ltd (Q4 FY26)
Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…
- Innovassynth Technologies (India) Ltd (Q4 FY26)
Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…
Frequently Asked Questions
What were Tata Chemicals Ltd Q4 FY26 results?
India is showing robust demand growth with higher capacity utilization across all sectors. Tata Chemicals is focused on disciplined execution, supply chain strengthening, and cost and cash flow discipline to improve margins and profitability over the next few quarters (Page 16).
What is Tata Chemicals Ltd share price analysis?
Tata Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹16,971 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tata Chemicals Ltd planning capital expenditure?
INR 1,300 crores Capex for FY27 primarily on: - Maintenance capex at Mithapur and US plants - Growth capex in South India (notably Silica plant at Cuddalore) - Capex for the recently acquired Singapore company - Silica Plant at Cuddalore: INR 775 crores investment for 50,000 tons capacity; detailed revenue/EBITDA guidance to be provided in Q1 FY27 call.
Keep Tata Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.